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A B S T R A C T
Background
Children with motor impairments often have the motor speech disorder dysarthria, a condition which effects the tone, strength and
co-ordination of any or all of the muscles used for speech. Resulting speech difficulties can range from mild, with slightly slurred
articulation and breathy voice, to profound, with an inability to produce any recognisable words. Children with dysarthria are often
prescribed communication aids to supplement their natural forms of communication. However, there is variation in practice regarding
the provision of therapy focusing on voice and speech production. Descriptive studies have suggested that therapy may improve speech,
but its effectiveness has not been evaluated.
Objectives
To assess whether any speech and language therapy intervention aimed at improving the speech of children with dysarthria is more
effective in increasing children’s speech intelligibility or communicative participation than no intervention at all , and to compare
the efficacy of individual types of speech language therapy in improving the speech intelligibility or communicative participation of
children with dysarthria.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2015 , Issue 7 ), MEDLINE, EMBASE, CINAHL
, LLBA, ERIC, PsychInfo, Web of Science, Scopus, UK National Research Register and Dissertation Abstracts up to July 2015,
handsearched relevant journals published between 1980 and July 2015, and searched proceedings of relevant conferences between
1996 to 2015. We placed no restrictions on the language or setting of the studies. A previous version of this review considered studies
published up to April 2009. In this update we searched for studies published from April 2009 to July 2015.
Selection criteria
We considered randomised controlled trials and studies using quasi-experimental designs in which children were allocated to groups
using non-random methods.
Data collection and analysis
One author (LP) conducted searches of all databases, journals and conference reports. All searches included a reliability check in which
a second review author independently checked a random sample comprising 15% of all identified reports. We planned that two review
authors would independently assess the quality and extract data from eligible studies.
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Main results
No randomised controlled trials or group studies were identified.
Authors’ conclusions
This review found no evidence from randomised trials of the effectiveness of speech and language therapy interventions to improve the
speech of children with early acquired dysarthria. Rigorous, fully powered randomised controlled trials are needed to investigate if the
positive changes in children’s speech observed in phase I and phase II studies are generalisable to the population of children with early
acquired dysarthria served by speech and language therapy services. Research should examine change in children’s speech production
and intelligibility. It must also investigate children’s participation in social and educational activities, and their quality of life, as well as
the cost and acceptability of interventions.
P L A I N L A N G U A G E S U M M A R Y
Speech therapy for children with dysarthria acquired before three years of age
The review question
This review aimed to investigate if therapy is generally effective for children with dysarthria acquired early in life, and if certain types
of therapy may be better than others.
Background
Dysarthria is a speech disorder linked to difficulties controlling the muscles needed for speaking. Children with dysarthria often
have shallow, irregular breathing which creates difficulties in generating sufficient breath to support speech. They have low pitched,
breathy or harsh voices, nasalised speech and very poor pronunciation. Together, these difficulties make the children’s speech difficult to
understand. Dysarthria is caused by neurological impairment and can arise early in children’s lives, from neurological damage sustained
before, during or after birth, such as in cerebral palsy, or in early childhood through traumatic brain injury or neurological disease.
Communication difficulties have a profound impact on children’s development. They reduce the quality of life of children with cerebral
palsy and place children at risk of social exclusion, educational failure and later unemployment. Speech and language therapy aims to
help children to control the movements for breathing and speech and so become more intelligible.
Study characteristics
We found no randomised controlled trials or controlled group studies which investigate the effects of speech and language therapy to
improve the speech of children with dysarthria acquired below three years of age.
Key results
Small, observational studies have suggested that, for some children, therapy might have been associated with positive changes in
intelligibility and clarity of voice. Rigorous research, using randomised controlled trials, is needed to evaluate if therapy can help children
to increase the intelligibility of their speech and if enhanced intelligibility increases children’s participation in social and educational
activities and their quality of life.
B A C K G R O U N D
Dysarthria is the term used to describe speech disorders that are
caused by neuromuscular impairments. People with dysarthria
have difficulties controlling and co-ordinating the speed, range,
strength and duration of movements needed for speech and as a
result their speech may be difficult to understand. For example,
difficulties with lip and tongue movements may cause ’tip’ to be
heard as ’sip’, ’hip’ or ’sieve’; ’beach’ to be heard as ’eats’; ’decide’
as ’sigh’ or ’say.’ Difficulties affecting the larynx alter the quality of
phonation (sound made when air passes through vibrating vocal
2Speech therapy for children with dysarthria acquired before three years of age (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
folds) and the pitch and loudness of speech. Speech may lack vari-
ation in loudness, pitch and rhythm or there may be inappropriate
swings in pitch and loudness. Difficulties with speech loudness,
pitch and rhythm may also be associated with poor respiratory
control. Speakers may have shallow breathing and have difficulty
co-ordinating exhalationwith phonation, giving themonly a small
amount of air on which to speak. Involvement of the soft palate
typically leads to perceptions of excess nasality in a person’s speech.
Symptoms of dysarthria can range from mild slurring of speech
sounds and slightly low pitch to complete inability to produce any
intelligible words.
Dysarthria in childhood is associated with congenital disorders
such as cerebral palsy (Lepage 1998; Kennes 2002; Bax 2006;
Odding 2006) andwith acquired aetiologies such as brain tumours
(Van Mourik 1996; Cornwell 2003; Richter 2005) and traumatic
brain injury (Chapman 2001;Netsell 2001;Cahill 2002). Approx-
imately 20% of children with cerebral palsy have speech which
is affected by dysarthria (Nordberg 2013). We do not know how
many additional childrenhave dysarthria arising fromother causes,
however, cerebral palsy and head injury remain two of the most
common medical causes of referral to speech and language ther-
apy (Petheram 2001). As the speech impairments of dysarthria
are neurologically based they do not resolve. Intervention seeks to
maximise children’s speech performance, teaching them how to
use different movements and lay down new motor programmes
for those movements. The learning of new motor behaviours re-
quires intensive practice (Schmidt 2005) involving considerable
therapy input over long time periods. Dysarthria therapy, there-
fore, potentially carries considerable costs to health services even
though the prevalence of the disorder in childhood may be small.
Speech and language therapy to reduce the motor speech im-
pairments experienced by children, and the intelligibility limita-
tions these impairments impose, has been advocated in textbooks
on dysarthria (Love 1992; Hayden 1994; Strand 1995; Hodge
1999; Yorkston 1999). An approach that targets all subsystems of
the vocal tract, breathing, nasal resonance, articulation and pitch
control is commonly described, and is similar to interventions
for adults with dysarthria acquired following neurological insults
(e.g. a stroke). Treatment focusing on one or more subsystem in
speech production may, for example, aim to help children control
their breathing and maintain adequate pressure for speech across
a phrase. This might involve teaching children how to start to
speak at the beginning of exhalation and how to split utterances
into smaller phases in which they can maintain adequate volume.
Intervention also involves slowing children’s speech rate, to allow
more precise movement of muscles in the oral tract. Strand 1995
and Yorkston 1999 also advocate increasing respiratory effort and
making jaw movements bigger in speech to increase oral cavity
volume, plus the use of speech and non-speech exercises to help
close the airway to the nose during speech. Treatment for articula-
tion has only been advised when other aspects of speech produc-
tion have been or are being addressed, as “imprecise production of
speech sounds (which is the most common perceptual characteris-
tic of dysarthria) is not simply an oral articulatory problem, and is
usually the result of laryngeal, velopharyngeal, respiratory and oral
articulatory problems” (Strand 1995, p134). Thus, more precise
articulation and improved intelligibility is thought to be achieved
through developing control of breathing for speech, increasing
background effort and slowing speech rate (Love 1992; Strand
1995; Yorkston 1996; Yorkston 1999). Treatment for prosody (in-
tonational contours of speech) and pitch control has been de-
scribed (Strand 1995; Yorkston 1999). This comprises exercises to
control the rate of words spoken and pauses used, increase volume
and possibly the use of pitch change. As treatment of isolated oro-
motor movements has not been found to affect speech (Weismer
2006), all therapy is functional, being directed at speech produc-
tion.
Although therapy for dysarthria in childhood has been described
in speech and language therapy textbooks, its effects are currently
unclear. An earlier version of this review (New Reference) showed
that there were a small number of phase I and II studies of therapy
for childrenwith early acquired dysarthria but no controlled group
studies. Speech and language therapists, therefore, have little ev-
idence on which to base treatment decisions. Some may provide
dysarthria intervention as there is no evidence to suggest that the
treatment does not work or causes harm. Others may withhold
treatment because there is no evidence showing its effectiveness
(Watson 2015).
Speech allows us to share complex thoughts and ideas quickly, and
is the most highly prized form of human communication. Com-
munication difficulties are associated with lower quality of life and
limited participation for children with cerebral palsy (Dickinson
2007; Fauconnier 2009) and children with speech and communi-
cation disorders are at risk of educational failure, social exclusion
and later unemployment (ICAN 2007). Such problems not only
have an obvious individual and family impact but also present
considerable societal and economic consequences. To ensure that
children have a clear means of communication, augmentative and
alternative communication (AAC) systems, such as symbol books
and speech synthesisers, are often provided. However, many chil-
dren still choose to communicate by speech. It is important to
investigate if the intelligibility of the speech of children with
dysarthria can be improved, as being more immediately under-
standablewillmaximise the chances of communication success and
may facilitate interaction in all areas of life.We aimed to conduct a
systematic review of the studies of speech therapy for children who
have acquired dysarthria early in life and to investigate the relative
effectiveness of different types of treatment. We focused on chil-
dren who acquire dysarthria below three years of age as they may
differ from children with later-acquired pathologies in terms of
their neural development, plasticity and recovery patterns; memo-
ries of fluent speech; retrieval of previously developed motor pro-
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grammes; self image (seeing themselves as a fluent speaker rather
than a person with a speech disorder); and patterns of communi-
cation development. Children with early acquired dysarthria may
never have developedmotor programmes for fluent speech or have
memories of non-dysarthric speech and may not see themselves as
an intelligible speaker. Furthermore, children with severe speech
and motor impairments arising from congenital pathologies or
those acquired in early infancy have highly unusual patterns of
communication development. They take a mainly responsive role
in communication and often fail to develop a full range of conver-
sational skills (Pennington 1999). Interventions for children who
acquire dysarthria at three years of age and above are the subjects
of a separate review (Morgan 2008).
O B J E C T I V E S
To assess whether any speech and language therapy intervention
aimed at improving the speech of children with dysarthria is more
effective in increasing children’s speech intelligibility or commu-
nicative participation than no intervention at all , and to compare
the efficacy of individual types of speech language therapy in im-
proving the speech intelligibility or communicative participation
of children with dysarthria.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We looked for randomised controlled trials and studies using
quasi-experimental designs in which children were allocated to
groups using non-random methods.
Types of participants
Any young person under 19 years of age who acquired dysarthria
below three years of age. No exclusions were made on the basis
of additional impairments (intellectual or sensory impairments,
the presence of epilepsy) or prior receipt of speech and language
therapy. We excluded children who did not have a definite diag-
nosis of dysarthria with underlying neurological/neuromuscular
pathology, and those who took part in studies that did not explic-
itly list dysarthria in their inclusion criteria. Thus, children who
had other types of speech disorders, such as articulation problems
without dysarthria, were not eligible for inclusion in this review.
Types of interventions
Any speech and language therapy aimed at improving children’s
speech, whether provided individually or in groups, in the child’s
home, school or health service settings, except where it is provided
as part of a holistic approach (e.g. as in conductive education
where there are no specific speech interventions). Therapy can be
provided directly by speech and language therapists (also known
as speech-language pathologists, speech pathologists) or by other
personnel under the direction of a speech and language therapist.
Types of outcome measures
Primary outcomes
Primary outcome measures relate to the extent to which children’s
speech is understood:
• objective measures of percentage of intelligible words (e.g.
Assessment of Intelligibility of Dysarthric Speech (Yorkston
1981) TOCS+ (Wilcox 1999; Hodge 2009);
• subjective intelligibility scales;
• communicative participation scales (e.g. Focus on
Communication Outcomes Under Six (FOCUS)
(Thomas-Stonnell 2010);
• coding schemes developed for individual research studies
that include validity and reliability data.
Secondary outcomes
Measures of speech subsystem function, which could underpin
intelligibility, such as respiration, phonation, nasality, articulation,
sound pressure level. Measures include:
• voice rating scales (Hirano 1981);
• oromotor skills tests (e.g. Robsertson Dysarthria
Assessment (Robertson 1982);
• Verbal Motor Production Assessment for Children (Hayden
1994);
• articulation tests;
• phonology tests (Diagnositic Evaluation of Articulation and
Phonology (DEAP) (Dodd 2006);
• acoustic measures of pitch and loudness;
• physiological tests e.g. of respiration and nasal emission.
Impact of intelligibility:
• quality of life (e.g. KIDSCREEN (Ravens-Sieberer 2005);
• generic measures of participation (e.g. CAPE (King 2004)).
Perceptions of treatment:
• satisfaction of participant and family with treatment;
• non-compliance with treatment.
Direct costs of treatment.
Adverse events, including time missed from education.
We planned to consider outcomes at the following time points:
4Speech therapy for children with dysarthria acquired before three years of age (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
• short term (less than one month following the end of the
intervention);
• medium term (one to three months following the end of
the intervention);
• and long term (more than four months following the end of
the intervention).
Search methods for identification of studies
Electronic searches
We searched for papers written in any language and in any setting
in the following databases from 1980 or from inception up until
the end of July 2015:
• The Cochrane Central Register of Controlled Trials
(CENTRAL; 2015 Issue 7) ;
• MEDLINE (Ovid);
• EMBASE (Ovid);
• CINAHL (EBSCOhost);
• ERIC (EBSCOhost);
• Psych-INFO (Ovid);
• Linguistics and Language Behaviour Abstracts (LLBA)
(ProQuest);
• Science Citation Index (Web of Science);
• Scopus;
• Dissertation Abstracts (ProQuest).
We used the search strategy developed from Robinson 2002 to
search MEDLINE and modified it to search the other databases
(see Appendix 1).
Searching other resources
We handsearched the following journals from their inception or
from 1980 until the end of July 2015 (unless otherwise speci-
fied): American Journal of Speech-Language Pathology; Applied
Psycholinguistics (1996 onwards); Augmentative and Alternative
Communication; Child: Care, Health and Development and the
Ambulatory Child; Child Language Teaching and Therapy; De-
velopmental Medicine and Child Neurology; European Journal of
Special Needs Education; Folia Phoniatrica; International Journal
of Disability, Development and Education; International Journal
of Language and Communication Disorders; International Jour-
nal of Rehabilitation Research; International Journal of Speech
Pathology; Journal of Child Psychology and Psychiatry; Journal
of Communication Disorders; Journal of Medical Speech-Lan-
guage Pathology; Journal of Psycholinguistic Research; Journal of
Special Education; Journal of Speech, Language and Hearing Re-
search; Speech, Language andHearing in Schools; Sprache Stimme
Gehoer. (The current titles are given for journals whose names
have changed since 1980.)
We checked published conference proceedings of the following
organisations: European Academy of Child Development (1996
to 2015), International Society for Alternative and Augmentative
Communication (1996 to 2015), American Speech and Hearing
Association (1999 to 2015), Royal College of Speech and Lan-
guage Therapists (1998 to 2015).
We checked the reference lists of all studies selected for possible
inclusion for other possible eligible studies.
Data collection and analysis
Selection of studies
One of the review authors (LP) independently screened each title
and abstract obtained from the database searches for inclusion.
One of the four review authors handsearched the journals lis ted
above. . Another review author independently selected 15% of the
reports found as a result of the searches at random and checked
them for inclusion eligibility by a second reviewer. Agreement
between the reviewers on the reports included in the reliability
check was 100%.
Data extraction and management
We planned that two of the thee review authors (LP, SR, NM)
would independently extract data intoReviewManager (RevMan)
5.3 (RevMan 2014). The data to be included is listed below.
• Participants:
◦ age;
◦ gender;
◦ age of onset of disorder;
◦ diagnosis of underlying disorder;
◦ type of dysarthria;
◦ severity of dysarthria relating to respiration,
phonation, nasality, articulation, sound pressure level,
intelligibility
• Co-morbidity
• Intervention:
◦ type of intervention;
◦ duration;
◦ frequency;
◦ provider: speech and language therapy (SLT)/other.
• Focus of intervention:
◦ respiration;
◦ phonation;
◦ nasality;
◦ articulation;
◦ sound pressure level;
◦ intelligibility.
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• Comparator intervention
◦ type of intervention
◦ duration
◦ frequency
◦ provider: SLT/other
◦ focus of intervention: respiration, phonation, nasality,
articulation, sound pressure level, intelligibility
We planned to develop and pilot data extraction sheets, which
would include a methodological assessment table for application
of the domains of risk of bias assessment (see below). We planned
to enter extracted data into RevMan 5.3 (RevMan 2014) , and to
contact authors of studies to request missing data.
Assessment of risk of bias in included studies
We planned that the two review authors who extracted data on an
individual study would also independently assess the study’s risk
of bias. We planned to resolve disagreements with the third review
author and to use the Kappa statistic to calculate agreement on
methodology assessment(Higgins 2011a).
We planned to rate individual criteria for risk of bias as ’adequate’,
’component not reported or unclear’ or ’component reported but
inadequate’, according to the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011b):
• Method of allocation (assignment of participants to group)
◦ Low risk: Well described randomised process.
◦ High risk: Non-random method (e.g. days of the
week, alternate).
◦ Unclear risk: Allocation is not described or description
leads to uncertainty in quality of allocation and possibility of
bias.
• Allocation concealment
◦ Low risk: Allocation was to be classed as adequately
concealed if allocation was done using a centralised system
independent of research team, use of pre-numbered opaque
sealed envelopes, generation of allocation by computer by person
not in charge of allocation.
◦ High risk: Providers of intervention undertake
allocation or research team allocate participants and have access
to participant characteristics.
◦ Unclear risk: Methods of concealment not described
or description does not allow bias to be ruled out.
• Blinding of outcome assessors. In the case of speech and
language therapy interventions neither participant nor provider
can be blind to the type of treatment given. Blinding in studies
in this review was to refer to blinding of study research team and
treatment provider to allocation process
◦ Low risk: Reports state that assessors were blind to
allocation.
◦ High risk: Reports suggested that assessors were likely
to know the group to which the participant had been allocated
(e.g. provided treatment, worked with person delivering
treatment).
◦ Unclear risk: No information on blinding of assessors.
• Loss to follow up
◦ Low risk: Attrition is similar in both conditions and
no greater than 25% of participants entering the trial.
◦ High risk: Loss of participants to follow up is greater
than 25% or is distributed unevenly across groups.
◦ Unclear risk: Loss of participants to follow up is not
reported.
◦ We planned to consider studies showing uneven loss
to follow up separately in sensitivity analyses.
• Intention to treat analysis
◦ Low risk: All trial participants entered into the analysis
in the group to which they were originally allocated.
◦ High risk: Trial participants who did not complete
their originally allocated treatment removed from the analysis.
◦ Unclear risk: Intention-to-treat analysis not reported.
Measures of treatment effect
Continuous data
We planned to summarise similar outcome measures with contin-
uous data using standardised mean differences (SMD).
Binary data
Binary data (e.g. reaching normal loudness: yes or no) may be used
in early reports. We planned to calculate a standard estimation
of the odds ratio (OR) for binary data, with a 95% confidence
interval (CI).
Dealing with missing data
Where information was unc l ear or missing we contacted study
authors to request clarification and additional data.
Assessment of heterogeneity
We planned to undertake meta-analysis of studies that investi-
gated similar interventions, used similar outcome measures and
included groups of participants who were clinically homogeneous.
Weplanned to assess possible inconsistency across studies using the
I2 statistic (Higgins 2003). For heterogeneous studies (Q-statistic
= 0.1 and I2 value of 50% or greater) we planned to conduct sub-
group analysis only. We planned to undertake a narrative review
of heterogeneous studies.
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Assessment of reporting biases
We aimed to investigate associations between effect size and study
precision in terms of sample size using funnel plots.
Data synthesis
Weplanned to assess the overall quality of the body of evidence us-
ing Grades of Recommendations, Assessment, Development and
Evaluation approach (GRADE) and assign it a rating of ‘high’,
‘moderate’, low’ or ‘very low’ quality. We will use GRADE profiler
(GRADEPro 2015) to construct a ‘Summary of findings’ table.
Subgroup analysis and investigation of heterogeneity
We planned to carry out subgroup analyses if studies fitting the
criteria for meta-analysis could be grouped further according to
participants’ type of dysarthria, severity of dysarthria, age.
Sensitivity analysis
We planned to undertake sensitivity analyses to assess the robust-
ness of review findings by investigating the impact of study qual-
ity:
• effects of randomisation;
• inadequate concealment;
• blinding of outcome assessors;
• unequal loss to follow up; and
• failure to employ intention-to-treat design.
R E S U L T S
Description of studies
Results of the search
We found a total of 1644 abstracts. Following removal of du-
plicates, we considered 48 full texts and 20 papers that ini-
tially appeared to meet the inclusion criteria for the review
(Fischer-Brandies 1987; Ray 2001; Hartley 2003; Fox 2005;
Puyuelo 2005; Pennington 2006; Fox 2008; Marchant 2008;
Cleland 2009; Wood 2009; Pennington 2010; Nordberg 2011;
Fox 2012; Levy 2012;Miller 2013; Pennington 2013;Ward 2013;
Ward 2014; Boliek 2015; Fox 2015). Two papers involved chil-
dren with Down’s Syndrome (Cleland 2009; Wood 2009); one
included children with a range of diagnoses (Romski 2010); all
others included children with cerebral palsy. Cleland 2009 and
Wood 2009 provided additional information to the published pa-
per stating that participants in their studies did not have dysarthria.
Romski 2010, was excluded because participants did not have con-
firmed dysarthria; additional information was requested but not
provided. All other studies were excluded on the grounds that they
used observational designs. Thus, no papers were identified as fit-
ting the inclusion criteria for this review. Agreement between the
reviewers on exclusion was 100%.
Included studies
No controlled studies were identified for this review.
Excluded studies
Excluded observational studies of speech and language
therapy intervention aimed at improving the speech of
children with dysarthria
Although not the focus of the review, we have summarised the
findings of the excluded observational studies of speech and lan-
guage therapy intervention aimed at improving the speech of chil-
dren with dysarthria identified by our searches in order show
developing evidence for dysarthria intervention for this clinical
group. Studies are described in Table 1 and we present a sum-
mary of their findings here. Most observational studies inves-
tigated interventions designed to control respiratory effort and
breath support for speech (Hartley 2003; Fox 2005; Puyuelo 2005;
Pennington 2006; Fox 2008; Pennington 2010; Fox 2012; Levy
2012; Miller 2013; Pennington 2013; Boliek 2015; Fox 2015).
Those that included motor learning principles of intensive prac-
tice, knowledge of results and fading feedback; multiple data col-
lection points pre and post therapy; and blinded outcome assess-
ment provide support for the potential effectiveness of this type of
intervention, with increases in speech intelligibility and improve-
ments in acoustic measures associated with voice quality being ob-
served (Pennington 2006; Fox 2008; Fox 2012; Miller 2013 and
Pennington 2010; Pennington 2013). Motor learning principles
were also used with proprioceptive feedback in the hierarchical
treatment PROMPT (Prompts for Restructuring Oral Muscular
Phonetic Targets (Hayden 1994)), which was associated with in-
creased oromotor movement and phonetic accuracy and possibly
improved intelligibility (Ward 2013; Ward 2014). Three studies
involved nonspeech exercises (Fischer-Brandies 1987; Ray 2001;
Puyuelo 2005) and indicated no improvement or were unable to
do so because of methodological flaws in the study design (e.g. lack
of blinding of assessors, indefinite intervention andmeasurement).
Electropalatography increased articulatory precision (Nordberg
2011).However, articulation therapywithout biofeedback showed
no effect on intelligibility or orofacial spasticity (Marchant 2008).
7Speech therapy for children with dysarthria acquired before three years of age (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Risk of bias in included studies
No controlled studies were identified for this review.
Effects of interventions
No controlled studies were identified for this review.
D I S C U S S I O N
Children with early acquired dysarthria often have reduced qual-
ity of life and are at risk of social exclusion, failure in education
and later unemployment. In addition, there can be psychosocial,
family and societal economic consequences. Children with se-
vere dysarthria are often prescribed augmentative and alternative
communication (AAC) systems (such as pictures, symbol or word
charts or voice output communication aids) to supplement their
natural modes of communication but children still prefer to com-
municate by speech wherever possible.
In this review we aimed to examine the effectiveness of inter-
ventions to improve the speech of children with dysarthria ac-
quired below three years of age. We searched for randomised con-
trolled trials and quasi-experimental designs but found no studies
of these types. Searches did identify a number of observational
studies, however, which have suggested that interventions which
follow motor learning principles may be associated with increases
in speech intelligibility, precision of articulatory movements and
voice quality and clarity for children with moderate and severe
dysarthria. Further interventions may have been reported in non-
controlled studies, but may not have been identified in this review.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
None
Implications for research
Observational studies identified during this review suggest that
several interventions which follow motor learning principles may
be associated with increases in speech intelligibility, voice quality
and clarity. Rigorous research, in the form of randomised con-
trolled trials, is needed to test the general effectiveness of speech
and language therapy for children with early acquired dysarthria.
Trials should include no therapy and attentional placebo control
arms. They should evaluate changes in speech impairment and
function, by measuring change in speech intelligibility, voice qual-
ity and clarity. And, as intelligible communication allows children
to engage with the world around them, trials should also investi-
gate the impact of intervention on children’s social participation.
This should include the extent and success of children’s commu-
nication with friends, family, teachers and strangers and their en-
gagement in social and educational activities. The consequent im-
pact of communication change on well-being should also be eval-
uated using quality of life measures. Such primary and secondary
effects may evolve over different periods of time. It is important,
therefore, that development and potential decay of effects is eval-
uated in the short (e.g. one month), medium (e.g. three months)
and long (e.g. six to twelve months) term. The costs of interven-
tion and the acceptability of therapy to children and their parents
must also be examined.
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C H A R A C T E R I S T I C S O F S T U D I E S
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(Continued)
Van Rees 2012 Not nonprogressive dysarthria under three years of age
Ward 2013 Single case experimental design
Ward 2014 Single case experimental design
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Wood 2009 Authors confirmed that participants did not have dysarthria
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Excluded, observational study findings
Study Study design Participants Intervention
type
Intervention
duration
Outcome
measures
Outcomes Timing
of outcome
measures
Method-
ological
problems
Fischer-
Brandies
1987
Observa-
tional
71 (37 F, 34
M) children
with
cerebral
palsy, age
4-14
years (mean
= 10 years)
; 42 spastic
type CP; 9
athetosis, 20
hypo-
tonia; orofa-
cial dysfunc-
tion
Oromo-
tor interven-
tion. Orofa-
cial reg-
ulation ther-
apy: wearing
of remov-
able plates
for upper
jaw, stimula-
tors on
palatal plate
for
tongue and
upper lip
plus motor
speech ther-
apy.
49 children
also received
physiother-
apy (Vojta or
Bobath
or Castillo-
Morales)
Appliances
worn for
several hours
per day (ex-
act duration
not spec-
ified) over a
mean period
of
15 months
(range 6
months to 3
years)
Impair-
ment:List of
symp-
toms, rated
as better or
worse after
treatment:
abnormal
tongue posi-
tion; limited
tongue mo-
bility (single
andmultiple
directions);
type of
tongue mo-
bil-
ity problem
(jerky, slow,
vermicular);
drooling;
labial sound
produc-
tion; palatal
sound pro-
duc-
tion; dental
sound pro-
duction;
feeding (sip-
ping, suck-
ing,
chewing,
choking)
Impair-
ment:Num-
ber of chil-
dren
showing im-
provement
when symp-
toms
rated as bet-
ter or worse
than at
start of ther-
apy by neu-
ropaediatri-
cian.
Improve-
ments
observed
(number
showing im-
provement/
number
showing
difficulties
in area
measured)
: abnormal
tongue
position 20/
59; limited
tongue mo-
bility 33/56;
jerky tongue
movements
13/23,
Be-
ginning and
end of treat-
ment; tim-
ing not spec-
ified.
Rater
not blind to
prior scores;
binary scale
used in out-
come mea-
sure (better/
worse) with
no informa-
tion on va-
lidity or reli-
ability
of outcome
measures;
no control
group; be-
fore and af-
ter treat-
ment mea-
sures only.
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Table 1. Excluded, observational study findings (Continued)
extremely
slow tongue
movements
10/21;
sucking 15/
31; sipping
23/30;
chewing 21/
37; severe
drooling 28/
40; labial
sounds 24/
38; palatal
sounds 26/
57; dental
sounds 24/
53. In 17
cases oral
functions
worsened
after therapy
Ray 2001 Observa-
tional
16 children
(7 F, 9
M) with
cerebral
palsy; aged
7 - 10 years
(mean = 8
years); mild
to moderate
spasticity.
All children
had scores
within nor-
mal limits
on Raven’s
Coloured
Progressive
Matrices
(Ravens-
Sieberer
2005), all
had passe d
pure tone
screening at
25 dB HL
bilaterally.
Oromo-
tor interven-
tion. Orofa-
cial
myofunc-
tional treat-
ment, focus-
ing on rest-
ing position
of lips closed
and tongue
under hard
palate, plus
strength ex-
ercises
for jaw, lips
and tongue
(exercises in-
volving iso-
lated move-
ments not
speech) and
pas-
sive stretch-
ing of lips
and tongue
Treatment
given 5 days
per week for
4 months.
Treatment
sessions = 15
min individ-
ual therapy
plus 10 min
group treat-
ment.
Parents were
provided
with
exercises for
children to
complete at
home
Impair-
ment: 4-
point rating
scale of
function of
lips, jaw and
tongue, by
1 orthodon-
tist and
2 speech
language
pathol-
ogists.
Percentage
errors on
produc-
tion of
phonemes
in 20 single
words, as
transcribed
indepen-
dently by
2 speech
language
Impair-
ment:
Group
difference
in pre and
post therapy
scores for lip
and tongue
position
(mean pre-
therapy
score = 2.21,
mean post-
therapy
score = 1.60;
P value = 0.
012) and for
percentage
phonemes
correct
(mean pre-
therapy
score = 1.
00, mean
post therapy
Pre and post
therapy.
Timings not
specified.
No blinding
of assessors;
no matura-
tional or ex-
per-
imental con-
trol; no fol-
low-up
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Children
had mild to
moderate
language
delay but
were able to
understand
simple
instructions
pathol-
ogists.
Percentage
errors then
converted
to 5-point
scale
score = 1.
62; P value
= 0.002)
Hartley
2003
Observa-
tional
4 boys with
predomi-
nantly
athetoid
type cerebral
palsy
aged 10 - 13
years (mean
11 years)
. Speech de-
scribed
as “border-
line intelligi-
ble”.
All children
used aug-
mentative
and alterna-
tive commu-
nication sys-
tems
Sub-
systems in-
tervention.
2 blocks of
therapy. 1st
block con-
centrated on
respiration
and phona-
tion. 2nd
block fo-
cused on ar-
ticulation
deficiencies
noted
during
assessment
Two 4-week
blocks of
therapy. Du-
ration and
frequency of
session were
not specified
Impair-
ment:
Impairment
scores on
Dysarthria
Profile
(Robertson
1982)
Activ-
ity: Percent-
age intelligi-
bility of sin-
gle word
speech on
Children’s
Speech
Intelligi-
bility Mea-
sure (Wilcox
1999) to one
familiar
and one un-
familiar lis-
tener per
participant
Impair-
ment:
Dysarthria
profile
showed pos-
itive change
for one child
Activity:
Group com-
parison of
intelli-
gibility data
across time.
No
difference in
intelligi-
bility across
data collec-
tion points
6
weeks prior
to therapy,
1 week prior
to therapy,
in
the week be-
tween ther-
apy blocks,
1 week af-
ter therapy
completion,
6 weeks af-
ter therapy
completion
Results of 4
cases
presented as
a group
for intelligi-
bility inves-
tigation; no
blind-
ing of out-
come asses-
sor; no mat-
urational or
exper-
imental con-
trol; no fol-
low-up
Marchant
2008
Single
case exper-
imental de-
sign
One 13 year
old girl with
spastic type
cerebral, and
severe spas-
tic
dysarthria.
Hearing and
vi-
sion within
normal lim-
its. Compre-
hension
Subsys-
temandoro-
motor inter-
vention.
2 blocks of
therapy. 1st
block: pho-
netic place-
ment, artic-
ulation ther-
apy involv-
ing teaching
of correct
2 blocks of
therapy each
comprising
10 sessions
of 45 min-
utes over 2
weeks.
Withdrawal
of
therapy for
2 weeks be-
tween ther-
apy blocks
Impair-
ment: Sur-
face EMG
amplitude
of left and
right obicu-
laris oris and
submental
muscles;
vowel
formant
frequencies;
duration of
Impair-
ment: Single
word intelli-
gibility im-
proved after
articulation
therapy and
improve-
ment was
maintained
post EMG
therapy
On each of 3
consecutive
days before
1st block of
therapy, on
the day fol-
lowing
1st block of
therapy, on
the day fol-
lowing the
2nd block of
Ther-
apists rating
speech were
not blind to
aims
of the study.
No matura-
tional or ex-
per-
imental con-
trol; no fol-
low-up
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adequate for
testing and
therapy pro-
cedures
movement
pat-
terns for tar-
get speech
sounds.
2nd block:
relaxation of
muscle
groups using
bio feedback
from surface
electromyo-
graphy
(EMG)
alternative
motion rates
of repeated
syllables;
perceptual
rating of
voice char-
acteristics
using Duffy
scale by 2
therapists
blind to
time of
recording
but not
to aims of
study; self-
perception
of speech
impairment
by partici-
pant
Activ-
ity: percent-
age intelligi-
bility in sin-
gle
words, sen-
tences and
paragraphs
Significant
difference
assumed if
post therapy
re-
sults were +/
- 1 SD from
pre therapy
scores
(pre-therapy
= 35%; post
articulation
therapy =
44.0%; post
EMG = 44.
45%). Slight
change
in motor
control
after EMG
therapy:
reduction
in ampli-
tude of
nonspeech
movements
(approxi-
mately 30
microvolts)
and gap
between
syllables
(approx 0.
1 sec). No
change in
participants’
view of
her speech
disorder
Activity: No
change
in intelligi-
bility at sen-
tence
or paragraph
level
therapy
Nordberg
2011
Observa-
tional
5 children
with cere-
bral palsy (2
F, 3 M) aged
7-13
years (mean
= 9 years)
with mild to
severe
Subsystem
interven-
tion. Elec-
tropalatog-
raphy
(EPG). Tar-
get sounds =
/t/, /d/, /n/, /
s/
15
minutes per
day, 5 days
per week for
8 weeks
Impair-
ment: Anal-
ysis of place
of ar-
ticulation as
shown
on EPG pat-
tern. Artic-
ulatory du-
Tongue
placement
for targets in
initial and
medial word
position
changed
post therapy
( P value ≤
1 week be-
fore and
1 week af-
ter therapy.
No further
information
given
No blinding
of assessors;
no matura-
tional or ex-
per-
imental con-
trol; no fol-
low-up
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Table 1. Excluded, observational study findings (Continued)
dysarthria. 3
children had
dysk-
inetic cere-
bral palsy, 2
spastic cere-
bral palsy; 4
walked
without
aids, 1 used a
walker
ration. Pho-
netic tran-
scription of
target sound
0.01). Artic-
ulation ap-
proach and
release time
reduced af-
ter therapy
for all partic-
ipants, with
wide
variation be-
tween par-
ticipants; all
children in-
creased con-
tact between
tongue
and alveolar
ridge; target
perceived as
/
t/ for all chil-
dren (no sta-
tistical test-
ing)
Ward 2013
and Ward
2014
Single
case exper-
imental de-
sign
6 children (3
F, 3 M) with
cerebral
palsy; aged
3-11 years
(mean = 5
years); mod-
erate to se-
vere speech
impairment;
< -1.5 SD
on articula-
tion test; 1
dyskinetic, 5
spastic type;
IQ ≥ 70; re-
ceptive lan-
guage
within 2SD;
hearing
within nor-
mal
limits; cor-
rectable vi-
Subsys-
tem inter-
vention.
PROMPT
(Prompts
for Restruc-
turing Oral
Musculature
Phonetic
Targets,
Hayden
2006):
focuses on
timing and
co-ordi-
nation of
movements
of speech
subsystems;
provides
tactile-
kinaesthetic
propriocep-
45- minute
sessions,
once weekly
for 20
weeks.
1 lower level
goal tar-
geted in first
10 weeks. 1
higher level
goal targeted
during sec-
ond 10
weeks. 3rd
goal selected
as control,
no interven-
tion.
Fidelity
of treatment
with proto-
col checked
by indepen-
Impair-
ment:
3D motion
analysis of
movement
accuracy
in 11 un-
trained
words re-
peated 5
times. Vi-
sual analysis
of perceived
movement
accuracy
and per-
ceived
phonetic
accuracy
(accurate/
inaccurate)
across 6
trained and
Impair-
ment:
Motion
analysis:
all children
changed
their lip
and/or jaw
movements
in untrained
words
following
treatment
( P value
≤ 0.05).
Perceived
move-
ment and
phonetic
accuracy
increased
during the
Kinematic
and intel-
ligibility
measures
week before
therapy,
at end of
each phase
of therapy.
Weekly
speech
probes for
measures of
perceived
movement
and pho-
netic accu-
racy during
5 baseline
therapy and
during 20
weeks of
Reliability
of 3D mo-
tion analysis
not tested.
Confi-
dence inter-
vals for intel-
ligibility test
taken from
the test stan-
dardis-
ation, which
did not
include chil-
dren
with speech
disorder
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Table 1. Excluded, observational study findings (Continued)
sual impair-
ment
tive feed-
back during
speech to
train jaw, lip
and tongue
movements
in a hi-
erarchical
sequence
dent thera-
pist blind to
study phase
(77.7%-
97%)
untrained
words se-
lected from
a corpus of
30
Activ-
ity: Percent-
age intelligi-
bility of sin-
gle
word speech
(Children’s
Speech
Intelligibil-
ity Measure)
to one lis-
tener blind
to speaker,
time
of recording
and aim of
research
treatment
phase for all
children and
was main-
tained above
baseline at
follow-up;
4 children
increased
move-
ment and
phonetic
accuracy
of higher
level target;
2 children
showed
change in
control
target (no
statistical
testing)
Activity: All
children in-
creased per-
centage in-
telligibility
after block 2
(mean
increase
= 24%); in-
crease main-
tained at fol-
low-up
therapy.
Follow-up
probe at 12
weeks post
therapy
Fox
2005 and
Fox 2012
Multiple
baseline sin-
gle case ex-
perimental
design with
repli-
cation across
participants
5 children (2
F, 3M), aged
5; 10-7; 10
years
with spastic
type cerebral
palsy
Lee Silver-
man Voice
Therapy
LOUD®
- targets res-
piratory ef-
fort and vo-
cal loudness
4 weeks:
16 1-hour
sessions
(4 times per
week for 4
weeks) plus
minimum
36 practice
sessions be-
tween treat-
ment ses-
sions. 4 chil-
dren re-
ceived ther-
Impair-
ment:
Acoustic
measures:
dB Sound
Pressure
Level (SPL)
, maximum
phonation
duration
in seconds,
harmonics
to noise ra-
Impair-
ment:
Change (no
overlapping
data points)
noted on
all acoustic
measures
in maxi-
mum per-
formance
tests post
therapy and
2 weeks
prior to
treatment,
2 weeks post
treatment
and
follow-up at
6 weeks post
treatment
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apy, 1 child
received no
treatment
tios (HNR)
in dB, max-
imum and
minimum
pitch in
Hz, pitch
range in Hz,
elicited in
maximum
perfor-
mance tests,
sustained
vowels,
sentence
repetition
and cartoon
description
Perceptual
measures:
therapists’
blinded
preferences
for record-
ings made
at different
times on
overall
loudness,
loudness
variability,
overall
pitch, pitch
variability,
articulatory
precision,
overall voice
quality;
parents’
ratings of
voice char-
acteristics
Activity:
Parent rat-
ings of spo-
ken commu-
nicative ac-
at follow-
up for 3 of
the 4 chil-
dren who
received
treatment.
Trends
noted in
sustained
phonation
and sen-
tence rep-
etition for
3 children.
No change
or reducing
scores for
child who
did not
receive
therapy.
Therapists
preferred
overall
loudness,
loudness
variabil-
ity, pitch
variability,
articulatory
precision,
overall voice
quality
of post-
treatment
recordings.
Parents
noted
change for
4 children,
but changes
not con-
sistently
maintained
at follow-up
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Table 1. Excluded, observational study findings (Continued)
tivity Activ-
ity: 3 chil-
dren judged
to be more
commu-
nicative after
ther-
apy, changes
maintained
for one child
Fox 2008 Observa-
tional
8 children (6
F, 2 M) aged
6 -12 years
with spastic
type cerebral
palsy
Lee Silver-
man Voice
Therapy
LOUD®
4 weeks:
16 1- hour
sessions
(4 times per
week for 4
weeks)
Impair-
ment:
Acous-
ticmeasures:
dB SPL, jit-
ter, HNR
and
duration of
phona-
tion in max-
imum per-
for-
mance tests
and in sen-
tence repeti-
tion
Perceptual
ratings: chil-
dren’s par-
ents rated
voice quality
using visual
analogue
scales
Impair-
ment:
Increase
in vocal SPL
in sustained
vowels (F (2-
12) = 5.14,
P value =
0.024) post
therapy and
follow-up;
improve-
ments in jit-
ter (measure
of voice
quality) post
therapy and
at follow-up
(F (2-
12) = 5.27,
P value = 0.
02); increase
in SPL of
spoken sen-
tences
after therapy
(F (2-12) =
5.29, P value
= 0.02)
Parents per-
ceived their
chil-
dren’s voices
as “louder”,
less
“nasal” and
more “natu-
ral” after
treatment
2 weeks
prior to
treatment,
2 weeks post
treat-
ment and 12
weeks post
treatment
No
blind rating
of per-
ceptualmea-
sures
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Fox 2015
and Boliek
2015
Observa-
tional
8 children (3
F, 6 M) with
cerebral
palsy aged 8-
16 (mean =
10 yrs) years
Dysarthria
char-
acterised as
mild to se-
vere spastic
or spastic-
flaccid type
GMFCS
(Palisano
1997) II-
V (median =
III)
Lee Silver-
man Voice
Therapy
LOUD®
with
daily main-
tenance ses-
sions (prac-
tice without
therapist)
for 12 weeks
4 weeks:
16 1-hour
sessions
(4 times per
week
for 4 weeks)
, followed by
daily main-
tenance ses-
sions (prac-
tice without
therapist)
for 12 weeks
Impair-
ment :
Speech:
speech rate
in diado-
chokinetic
(DDK)
tasks/
pataka/;
dB SPL in
sentence
repetition.
Neuro-
physiology:
Diffusion
Tensor
Imaging
DTI),
functional
Magnetic
Resonance
Imaging
(fMRI)
, inter-
muscular
coherence
comparison
pre and post
intervention
and with
typically
developing
controls
matched for
age and sex
Activ-
ity : Percent-
age Intelligi-
bility in re-
peated sen-
tences. Sub-
jective rat-
ings of intel-
ligibility and
communi-
Impair-
ment:
No change
in group
mean SPL or
DDK rate.
Mean
increase in
max-
imum inter-
muscular
coherence in
DDK at fol-
low-up
(t (7) = 2.34
P value < 0.
02)
Change
in left corti-
cospinal
tract onDTI
(fractional
anisotropy
change > 1
SD of typ-
ically devel-
op-
ing controls)
. Change in
fMRI acti-
vation maps
post therapy
(t > 3.11, P
value < 0.
001)
Activity:
Group in-
crease in in-
telligibil-
ity post ther-
apy (t (7) =
3.49, P value
< 0.01) were
maintained
2 weeks
prior to
treatment,
2 weeks post
treatment
and fol-
low-up at 12
weeks post
treatment
No
blind rating
of per-
ceptualmea-
sures. Fox
2015
states 9 chil-
dren partici-
pated but re-
sults
provided for
8
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cation per-
formance
at follow-up.
All parents
rated their
child’s intel-
ligibility as
better after
therapy
Levy 2012 Observa-
tional
3 girls with
spastic
type cerebral
palsy. P1 age
8 years, mild
dysarthria;
P2 3 yrs,
moderate
dysarthria;
P3 9 yrs,
moderate
dysarthria
and apraxia,
cogni-
tive impair-
ment and
language de-
lay
P1
and P2: Lee
Silverman
Voice Ther-
apy
LOUD®,
P3: Therapy
adapted
from
Pennington
2010:
discussionof
pos-
ture, speech
clarity,mon-
itoring of
speech,
breathing at
start of exha-
lation, activ-
ities focus-
ing on stress,
intensity
and breath-
ing control
P1 and P2: 4
ses-
sions of 50-
60 min per
week plus 10
min home-
work for 4
weeks
P3: 2 ses-
sions of 50
minutes per
week
with home-
work for 4
weeks
Impair-
ment : dB
SPL;
artic-
ulation (Ari-
zona Articu-
lation Profi-
ciency Scale)
.
Activ-
ity : Listen-
ers blind to
the time of
speech
recording
rated ease of
understand-
ing and
made rated
preference
for paired
recordings
Impair-
ment: All
participants
increased ar-
ticu-
latory profi-
ciency score
by
9-19 points.
P1 and P2
increased dB
SPL
in words or
spontaneous
speech by >
5 dB SPL;
P3 words
and sponta-
neous
speech
decreased by
6 dB SPL
Activity:
Post- ther-
apy speech
recordings
preferred
and judged
as eas-
ier to under-
stand for all
participants
2
weeks prior
to interven-
tion; during
1s t week
post
intervention
No random
allocation of
participant
to treat-
ment. Par-
ticipants dif-
fered in co-
oc-
curing diffi-
culties likely
to af-
fect response
to treat-
ment. Treat-
ment inten-
sity differed
between in-
terventions
Pennington
2006
Observa-
tional
6 partici-
pants (4 F,
2 M), aged
10-18 years)
all of whom
had cerebral
palsy: 4
spastic type,
Whole sys-
tem ap-
proach, tar-
geting con-
trol of
breath sup-
ply for
speech pro-
Indi-
vidual ther-
apy for 20-
30 min. 5
sessions per
week for 5
weeks
Activ-
ity: Percent-
age of single
words (Chil-
dren’s
Speech
Intelligibil-
ity Measure)
Activity:
Individual
results
presented
for each
participant
and group.
4 students
1 week prior
to therapy, 1
week
after therapy
completion,
6 weeks af-
ter therapy
completion
No con-
trol group or
matu-
rational con-
trol
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1 mixed
type, 1
ataxic type.
Hearing
within nor-
mal limits.
2 children
with lan-
guage delay,
but com-
prehension
adequate
for simple
verbal in-
structions;
4 children
language
comprehen-
sion within
normal
limits. All
used speech
to com-
municate.
Dysarthria
rated as mild
to severe
by local
therapists
duction and
prosodic
contrasts
and
connected
speech
(elicited in
pic-
ture descrip-
tion) intelli-
gible
to three un-
familiar lis-
teners. Lis-
teners blind
to time of
recording
Other:
Semi-struc-
tured inter-
view on ac-
ceptability
of treatment
increased
single word
intelli-
gibility
immediately
after therapy
(2%-25%),
but gains in
intelligibil-
ity were not
maintained
at follow-
up. 2 stu-
dents did
not increase
intelligibil-
ity of single
words.
Increases in
connected
speech in-
telligibility
were ob-
served for 3
participants
(75-13%),
gains were
not main-
tained at
follow-up.
No group
change in
intelligibil-
ity
Other: 3
par-
ticipants re-
ported that
the duration
and in-
tensity of the
treatment
were accept-
able. 3 par-
ticipants re-
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ported that
the
therapy was
too intensive
and that ei-
ther 4 weeks
of therapy 5
times per
week or 3
sessions per
week for 5
weeks would
be preferred
Pennington
2010; Miller
2013; Rob-
son 2009
Observa-
tional
16 partici-
pants (9 F,
7 M); aged
12-18 years
(mean = 14
years, SD =
2). 15 with
cerebral
palsy, 1 with
Worster-
Drought.
9 children
had bilateral
spastic type
cerebral
palsy, 2 had
dyskinetic
type, 4
had mixed
(spastic and
dyskinetic)
and 1 child
had Worster
Drought.
GMFCS
ranged from
I-V (median
= IV).
Dysarthria
rated mod-
erate to
severe by
referring
speech and
Whole
systems ap-
proach
which fo-
cused on sta-
bilising
the students’
respiratory
and phona-
tory effort
and control,
speech rate
and phrase
length/
syllables per
breath
3 in-
dividual ses-
sions of 30-
40 min each
per week for
6 weeks
Impair-
ment:
Perceived
voice quality
rating scale
(GRBAS:
Grade,
Roughness,
Breathiness,
Aesthenia,
Strain,
Hirano
1981),
therapists
rated speech
recordings
blind to
time of
recording.
Acoustic
measures:
HNR,
amplitude,
shimmer
(regularity
of ampli-
tude o f
vocal fold
vibrations)
, jitter (r
egularity of
f requency
of vocal fold
Impair-
ment: Slight
reduction
in fun-
damental
frequency,
intensity
and jitter
of children’s
voices (all P
value < 0.
05). Increase
in speak-
ing time
between
pauses by
approx 1
second.
Aesthenia
reduced
post therapy
(-0.26 on
4-point
GRBAS
scale, effect
size 0.4).
No other
differences
in voice
quality were
perceived.
Aesthenia
6 weeks and
1 week be-
fore therapy,
1 week and
6 weeks af-
ter therapy
completion
No
treatment
integrity
checks;
longer term
effects of in-
ter-
ventionwere
not evalu-
ated. Partici-
pants
acted as own
controls, no
control
group
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Table 1. Excluded, observational study findings (Continued)
language
therapists.
All children
were able
to compre-
hend simple
instructions
v ibratio
n s ) , F0
mean (av-
erage fun-
damental
frequency)
, rate with
pauses, rate
without
pauses, time
with pauses
and time
without
pauses
Activity:
Mean per-
centage
intelligi-
bility of
single words
(Children’s
Speech
Intelligibil-
ity Mea-
sure) and
connected
speech to 3
familiar and
3 unfamiliar
listeners.
Listeners
blind to
time of
recording
for intel-
ligibility
measures
Other:
Question-
naire on the
acceptability
of therapy,
using Likert
scales
was weakly
associated
with re-
duced intel-
ligibility (R
-0.11, 95%
CI -0.58 to
-0.15, with
-10.7%
reduction in
intelligibil-
ity with an
increase of
1 point on
the aesthe-
nia rating
scale). No
association
between
change in
intelligi-
bility and
any other
GRBAS
ratings
Activ-
ity: Statisic-
tially signifi-
cant gains in
intelligibil-
ity post ther-
apy: on aver-
age familiar
listeners un-
derstood
14.7% more
single words
and 12.1%
more words
in
connected
speech after
the therapy;
unfamiliar
listeners un-
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Table 1. Excluded, observational study findings (Continued)
derstood
15.0% more
single words
and 15.9%
more words
in
connected
speech after
therapy (all
P value < 0.
05)
Other: All
children re-
ported that
the ther-
apy was ac-
ceptable and
would rec-
ommend it
to a friend
Pennington
2013
Observa-
tional
15 partici-
pants (6 F,
9 M) aged
5-11 years,
mean = 8
years, SD =
2). 13 with
cerebral
palsy, 2 with
Worster-
Drought.
8 children
had spastic
type cerebral
palsy, 4 had
dyskinetic
type and
1 ataxia.
GMFCS
ranged from
II-IV (me-
dian = II).
Dysarthria
rated mod-
erate to
severe by
referring
speech and
Whole
systems ap-
proach
which fo-
cused on sta-
bilising
the students’
respiratory
and phona-
tory effort
and control,
speech rate
and phrase
length/
syllables per
breath
3 in-
dividual ses-
sions of 30-
40 min each
per week for
6 weeks
Activity:
Mean per-
centage
intelligi-
bility of
single words
(Children’s
Speech
Intelligibil-
ity Mea-
sure) and
connected
speech to 3
familiar and
3 unfamiliar
listeners.
Listeners
blind to
time of
recording
for intel-
ligibility
measures
Partici-
pation: FO-
CUS (Focus
Activity:On
aver-
age familiar
listeners un-
derstood
10.8% more
single words
and 9.4%
more words
in
connected
speech after
the therapy.
Unfamiliar
listeners un-
derstood 9.
3% more
single words
and 10.5%
more words
in
connected
speech after
therapy (all
P value < 0.
05)
6 weeks and
1 week be-
fore therapy,
1, 6 a nd
12 weeks af-
ter therapy
completion
No
treatment
integrity
checks. Par-
ticipants
acted as own
controls, no
control
group
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Table 1. Excluded, observational study findings (Continued)
language
therapists.
All children
were able
to compre-
hend simple
instructions
on Commu-
nicaiton
Outcomes
Under Six,
Thomas-
Stonnell
2010) mea-
sure of per-
ceived com-
munica-
tion activity
and partici-
pation com-
pleted by
parents
Other:
Question-
naires on the
effective-
ness and ac-
ceptability
of therapy,
using Likert
scales
Participa-
tion: Mean
improve-
ment in FO-
CUS score =
30.
3 (95% CI
10.2 to 50.
4). No as-
sociation be-
tween
change
in FOCUS
score
and percent-
age intelligi-
bility
observed
Other: 12/
15 parents
rated
therapy:
8 rated ther-
apy as hav-
ing good ef-
fects, 4 rated
therapy as
havingmod-
erate effects
Puyuelo
2005
Observa-
tional
10 children
(3 F; 7M)
with cere-
bral palsy ,
aged 3 years
at the start of
the study. 5
children
had athetoid
type CP, 4
spastic type
and 1 had
ataxia. Chil-
dren had
“absence of
articulated
speech”.
Hearing and
lan-
First block
of therapy
focused on
increasing
control
of oral
movement
used in
articulation,
chewing and
expiration.
Second
block of
therapy
focused on
controlling
exhalation
for speech
and co-or-
2 blocks of
treat-
ment. Each
block com-
prised
11 months
of twice-
weekly ther-
apy, each
session last-
ing 30 min
Impair-
ment:
Impair-
ment scores
on Spanish
adaptation
of
Robertson
Dysarthria
Pro-
file . Spec-
trographic
analysis
of a repeated
sentence
Impair-
ment:
Group
results
presented.
Following
the first
treatment
only voice
control
increased.
Following
the second
treatment
scores in-
creased for
respiration,
voice, artic-
Before inter-
vention, be-
tween
first and sec-
ond inter-
ventions, af-
ter interven-
tion 2. Ex-
act timing of
measures
not specified
No control
group; long
duration of
treatment;
no con-
trol of mat-
urational ef-
fects;
no blinding
of assessor
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Table 1. Excluded, observational study findings (Continued)
guage com-
prehension
within nor-
mal limits
dination of
exhalation
and phona-
tion; voice
training;
and prosody
(intonation,
pausing,
rhythm
and sound
duration).
In the sec-
ond block
of therapy
advice was
given to
parents on
stimulating
communi-
cation, and
children
engaged in
story telling
and recall
to practice
their speech
skills with
their par-
ents.
Whilst
receiving the
above thera-
pies children
also received
Bobath neu-
rodevelop-
mental
treatment
ulation, in-
telligibility
and prosody
(all P value <
0.05). Spec-
trographic
analysis was
also possible
at the end of
the second
treatment,
as children
had devel-
oped some
spoken
output
GMFCS = Gross Motor Function Classification System (Palisano 1997)
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